Nutex Health Inc. (NUTX) reported robust earnings and revenue growth for the third quarter and nine months ended September 30, 2025, sharply outpacing its 2024 performance.
The Houston-based physician-led healthcare company operates through two divisions: the Hospital Division and the Population Health Management Division.
Net income attributable to Nutex Health for the third quarter of 2025 soared to $55.4 million or $7.76 per diluted share, compared to a net loss of $8.8 million or $1.72 per share in the third quarter of 2024.
Total revenue for Q3 2025 climbed to $267.8 million, an increase of nearly 239.9% from $78.8 million in Q3 2024.
The Hospital division contributed $260.2 million in Q3, 2025, up from $71.7 million in the prior year, driven by higher acuity claims and success in arbitration under the Independent Dispute Resolution (IDR) process.
The Population Health Management Division added $7.56 million, slightly above $7.06 million in Q3 2024.
For the nine months ended September 30, 2025, Nutex Health reported total revenue of $723.6 million, more than tripling from $222.3 million in the same period in 2024, representing a 225.5% increase.
Net income for the nine months of 2025 reached $59 million, reversing a net loss of $9.5 million a year earlier.
Cash and cash equivalents stood at $166 million as of September 30, 2025, compared to $46.9 million at the end of Q3 2024.
Total assets rose to $964.5 million in 2025 from $655.3 million at year-end 2024.
The company has also regained Nasdaq compliance following timely SEC filings.
NUTX has traded in the range of $28.12 to $184.27 over the past year. The stock closed yesterday's trading at $112.19, up 13.09%, and is up over 7% at $120 in premarket trading Thursday.
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.